S. Hoerer

422 total citations
8 papers, 319 citations indexed

About

S. Hoerer is a scholar working on Molecular Biology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S. Hoerer has authored 8 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S. Hoerer's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Chemical Synthesis and Analysis (1 paper) and Cholesterol and Lipid Metabolism (1 paper). S. Hoerer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Chemical Synthesis and Analysis (1 paper) and Cholesterol and Lipid Metabolism (1 paper). S. Hoerer collaborates with scholars based in Germany, United States and Australia. S. Hoerer's co-authors include Herbert Nar, Armin Heckel, Angela Schmid, Lei Chen, Zhixing Chen, Chengcheng Guan, Yuan Zhang, Rui Liu, Gerald J. Roth and Patrick Schulz and has published in prestigious journals such as Nature, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

S. Hoerer

8 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Hoerer Germany 8 212 80 75 50 44 8 319
Zachariah H. Foda United States 7 275 1.3× 39 0.5× 40 0.5× 46 0.9× 29 0.7× 9 400
Marika Manolopoulou United States 8 300 1.4× 87 1.1× 68 0.9× 8 0.2× 36 0.8× 9 465
Bénédicte Kiehr Denmark 8 270 1.3× 52 0.7× 141 1.9× 52 1.0× 208 4.7× 14 496
Wei-Li Liao United States 11 199 0.9× 77 1.0× 84 1.1× 37 0.7× 35 0.8× 11 316
Liusheng Zhu United States 12 164 0.8× 67 0.8× 83 1.1× 13 0.3× 97 2.2× 18 379
Koc-Kan Ho United States 12 328 1.5× 73 0.9× 20 0.3× 18 0.4× 16 0.4× 17 476
Changyou Zhou United States 15 300 1.4× 106 1.3× 98 1.3× 21 0.4× 107 2.4× 25 505
Angela Oh United States 8 518 2.4× 188 2.4× 28 0.4× 45 0.9× 12 0.3× 18 672
Geoffrey T. Struble United States 7 223 1.1× 96 1.2× 23 0.3× 26 0.5× 31 0.7× 9 386
L. Anders Svensson Denmark 10 215 1.0× 38 0.5× 17 0.2× 21 0.4× 40 0.9× 13 403

Countries citing papers authored by S. Hoerer

Since Specialization
Citations

This map shows the geographic impact of S. Hoerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hoerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hoerer more than expected).

Fields of papers citing papers by S. Hoerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Hoerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hoerer. The network helps show where S. Hoerer may publish in the future.

Co-authorship network of co-authors of S. Hoerer

This figure shows the co-authorship network connecting the top 25 collaborators of S. Hoerer. A scholar is included among the top collaborators of S. Hoerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Hoerer. S. Hoerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Liu, Rui, Chengcheng Guan, Yuan Zhang, et al.. (2021). Structural basis of inhibition of the human SGLT2–MAP17 glucose transporter. Nature. 601(7892). 280–284. 90 indexed citations
2.
Gerlach, Kai, Scott Hobson, Christian Eickmeier, et al.. (2018). Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators. Bioorganic & Medicinal Chemistry. 26(12). 3227–3241. 10 indexed citations
3.
Tautermann, Christofer S., Florian Binder, Frank Büttner, et al.. (2018). Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule. Journal of Medicinal Chemistry. 62(1). 306–316. 30 indexed citations
4.
Kuttruff, Christian A., Marco Ferrara, Tom Bretschneider, et al.. (2017). Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo. ACS Medicinal Chemistry Letters. 8(12). 1252–1257. 35 indexed citations
5.
Seeliger, Daniel, Patrick Schulz, Tobias Litzenburger, et al.. (2015). Boosting antibody developability through rational sequence optimization. mAbs. 7(3). 505–515. 55 indexed citations
6.
Roth, Gerald J., Armin Heckel, Matthias Grauert, et al.. (2010). Design, Synthesis, and Evaluation of Indolinones as Inhibitors of the Transforming Growth Factor β Receptor I (TGFβRI). Journal of Medicinal Chemistry. 53(20). 7287–7295. 30 indexed citations
7.
Lamla, Thorsten, S. Hoerer, & Margit Bauer. (2006). Screening for soluble expression constructs using cell-free protein synthesis. International Journal of Biological Macromolecules. 39(1-3). 111–121. 11 indexed citations
8.
Hoerer, S., et al.. (2003). Crystal Structure of the Human Liver X Receptor β Ligand-binding Domain in Complex with a Synthetic Agonist. Journal of Molecular Biology. 334(5). 853–861. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026